June 11, 2018 / 4:13 PM / 2 months ago

BUZZ- Correvio jumps after FDA allows resubmission of marketing application

** U.S.-listed shares of Canadian drugmaker jump 37 pct to $2.85 after FDA agrees to allow resubmission of marketing application for heart drug

** Stock is second among top advancers across U.S. exchanges

** Correvio formerly known as Cardiome Pharma says FDA also agrees to schedule a pre-marketing application meeting and expects it to take place in Q4

** Co’s heart drug Brinavess is approved for marketing in Europe and Canada

** Canada-listed shares also jumped nearly 42 pct

** Including sessions gains, U.S.-listed shares have nearly doubled in value YTD (Reporting by Shreyashi Sanyal in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below